121
Participants
Start Date
June 18, 2010
Primary Completion Date
March 30, 2016
Study Completion Date
March 30, 2016
rhIGF-I/rhIGFBP-3
Continuous intravenous infusion
West Virginia University Hospital, Morgantown
Vidant Medical Center, Greenville
Georgia Regents Medical Center, Augusta
University of Padua, Padua
University of Wisconsin - Madison, Madison
University of Oklahoma Health Sciences Center, Oklahoma City
Univ of California Irvine Med Center, Irvine
University of South Alabama Children's and Women's Hospital, Mobile
Univ of Mississippi Medical Center, Jackson
D.A.I. Materno Infantile, S.O.D. Neonatologia e Terapia Intensiva Neonatale - Azienda Ospedaliero-Universitaria Careggi, Florence
U.O.C Patologia e Terapia Intensiva Neonatale, Istituto Giannina Gaslini-Istituto Pediatrico di Ricovero e Cura a Carattere Scientifico, Genova
Dipartimento per la Tutella della Salute della Donna e della Vita Nascente, del Bambino e dell'Adolescente-U.O.C. Neonatologia-Poli. Gemelli, Rome
Skånes University Hospital Lund, Lund
Karolinska Universtitetssjukhuset i Huddinge, Stockholm
Alder Hey Children's NHS Foundation Trust, Liverpool
VU medical Center, Amsterdam
Instytut Centrum Zdrowia Matki Polki, Lódz
Ginekologiczno-Położniczy Szpital Kliniczny Uniwersytetu Medycznego w Poznani, Poznan
Addenbrookes Hospital, Cambridge
St Peter's Hospital; Ashford & S, Chertsey
University Hospital, Coventry
UCL EGA Institute for Women's Health, London
St. Mary's Hospital, Manchester
Norfolk and Norwich University, Norwich
Lead Sponsor
Shire
INDUSTRY